Renal medullary carcinoma (RMC) is a rare entity with poor prognosis bearing inactivating genomic alterations in <i>SMARCB1/INI1</i> resulting in the loss of expression of INI1 and occurring in young patients with sickle cell trait or sickle cell disease. The gene discussed is SMARCB1; the disease is sickle cell disease.